EPA +
EPA +, licence 80029964: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- NutraSea Dry Eye Targeted Omega-3
- Licence holder
- Nature's Way of Canada Ltd.
- NPN or DIN-HM
- 80029964
- Status
- Active licence
- Licence date
- 28 February 2012
- Revision date
- 12 February 2026
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
Medicinal composition not provided.
Non-medicinal ingredients
Tocopherols, Natural Citrus Flavour, Extrait de fruit de monk, Extrait de thé vert, Triglycérides à chaîne moyenne
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adolescentes | minimum: 14.0 Année(s) ; maximum: 18.0 Année(s) | 1.0 Cuillère à thé | 1.0 Tous les jours |
| Adultes | minimum: 19.0 Année(s) | 1.0 Cuillère à thé | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of omega-3 and omega-6 fatty acids beneficial for the maintenance of good health. Helps relieve symptoms of Dry Eye Syndrome. Helps improve symptoms of Dry Eye Syndrome. Helps provide relief/improve symptoms of dry eye syndrome including support for proper tear function (decreased rate of tear evaporation and increase in tear secretion). Helps support proper tear function in persons with Dry Eye Syndrome. Helps decrease the rate of tear evaporation in persons with Dry Eye Syndrome. Helps increase tear secretion in persons with Dry Eye Syndrome.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80029964
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.